-
Stattic and the Translational Logic of STAT3 Biology
2026-08-20
STAT3 is a convergence point between inflammatory signals, tumor adaptation, and treatment resistance. This thought-leadership analysis positions Stattic as a mechanistic research probe for connecting microbiome-driven signaling with cancer phenotypes, while defining the controls and limitations required for translationally credible conclusions.
-
KR-12 in Mouse Colitis: Findings and Methods
2026-08-20
Fabisiak and colleagues investigated KR-12, the shortest active fragment of human cathelicidin LL-37, across TNBS- and DSS-induced mouse models of colitis. The study found that KR-12 reduced macroscopic, microscopic, ulceration, colon-damage, and myeloperoxidase outcomes while also altering recoverable stool bacteria, supporting further study of this human antimicrobial peptide as a candidate inflammation-modulating therapy.
-
Sodium Ascorbate Cancer Assay Workflows
2026-08-19
Sodium Ascorbate enables solvent-aware studies of intracellular ROS, tumor-cell injury, proliferation, and motility in glioblastoma and prostate cancer models. This practical guide combines dose–time optimization with a cautious biomarker bridge to GPNMB-based immunotherapy research.
-
JSH-23 NF-κB Inhibitor: Workflow Guide
2026-08-19
JSH-23 is a mechanism-focused NF-κB inhibitor for separating p65 nuclear activity from upstream IκB degradation in inflammation research. This practical guide covers cell-based assays, translational disease models, protocol design, and troubleshooting for more interpretable NF-κB signaling pathway study results.
-
Acetylcysteine Workflows for Redox-Aware Models
2026-08-18
Acetylcysteine, or N-acetyl-L-cysteine, helps researchers separate oxidative injury from downstream assay artifacts in cell, organoid, hepatic, respiratory, and neurodegeneration models. This practical guide covers concentration screening, redox-rescue controls, nanoplatform assay compatibility, and troubleshooting for more interpretable results.
-
GPR30 in Spinal CCK+ Neurons and Neuropathic Pain
2026-08-18
The reference study identifies GPR30 in spinal cholecystokinin-positive neurons as a molecular and circuit-level contributor to nerve-injury-induced pain. By combining cell-type analysis, synaptic measurements, pathway manipulation, and behavioral testing, it links spinal GPR30 to AMPA-mediated sensitization and descending input from the primary somatosensory cortex.
-
VE-822 and the Hidden DDR–Genome Axis
2026-08-17
VE-822 is a selective ATR inhibitor for dissecting replication stress, persistent DNA damage, and cancer chemoradiotherapy sensitization. This article connects ATR pathway experiments with nuclear cGAS–TRIM41 control of retrotransposition and shows how that emerging biology can improve assay design.
-
From dNTP Control to Translational Delivery
2026-08-17
Reliable DNA synthesis begins with disciplined substrate control. This thought-leadership article connects an equimolar 10 mM dNTP mixture with the analytical demands of translational nucleic acid research, using recent evidence on cholesterol-dependent LNP trafficking to show why upstream reagent standardization and downstream delivery biology should be managed as linked but distinct variables.
-
JAK Inhibitors and Endothelial Cardiovascular Effects
2026-08-16
This 2025 ACR Open Rheumatology study compares six JAK inhibitors in cytokine-stimulated human endothelial cells, separating suppression of inflammatory cytokines from effects on adhesion, coagulation, and apoptosis. Its findings show that reduced endothelial inflammation does not necessarily indicate a normalized vascular phenotype, with important compound- and concentration-dependent differences.
-
3-Deazaadenosine for Reliable Methylation Assays
2026-08-15
Learn how 3-Deazaadenosine, SKU B6121, can help laboratories interpret viability, proliferation, cytotoxicity, methylation, and viral infection experiments. This scenario-based guide connects SAH hydrolase inhibition with practical stock preparation, assay controls, data interpretation, and product selection.
-
SD 169: Indole-5-carboxamide p38 MAPK Inhibitor
2026-08-15
SD 169, also called indole-5-carboxamide, is a selective ATP-competitive inhibitor of p38α and p38β MAPKs. Product information supports its use as a research tool in p38 signaling, type 1 diabetes research, Schwann-cell biology, and axonal regeneration research.
-
Wortmannin: From PI3K Mechanism to Translation
2026-08-14
Wortmannin is a powerful mechanistic probe for testing how PI3K/Akt signaling shapes tumor growth, ferroptosis resistance, autophagy, and apoptosis. This translational guide connects its irreversible pathway logic with FAT4-deficient hepatocellular carcinoma, experimental controls, model selection, and the strategic limits of tool-compound evidence.
-
N1-Methylpseudouridine for Reliable Cell Assays
2026-08-13
Learn how N1-Methylpseudouridine and SKU B8340 can reduce translation-related variability when researchers evaluate cell viability, proliferation, or cytotoxicity after mRNA delivery. This scenario-based guide connects formulation, controls, storage, and interpretation to published mRNA performance data.
-
MDM1, p53, and Chemoradiotherapy Sensitivity in CRC
2026-08-13
The reference study identifies MDM1 as a functional determinant of colorectal cancer chemoradiotherapy response, rather than merely a correlational biomarker. Its experiments connect MDM1 overexpression with reduced YBX1 occupancy at the TP53 promoter, higher p53 expression, and enhanced apoptosis, providing a mechanistic framework for resistance studies.
-
Cefepime (BMY-28142) Research Workflows
2026-08-13
Build reproducible Cefepime assays for bacterial infection models, central nervous system infection research, and resistance-mechanism studies. This guide combines fresh-solution handling, time-kill experiments, barrier-model controls, and semi-mechanistic PKPD thinking while clearly separating Cefepime evidence from findings generated with other β-lactams.
448 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page